Which meditation works best for cancer survivors? a new study aims to find out

NCT ID NCT06500377

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This pilot study explores how four different meditation practices—breathing only, focused attention only, mindfulness only, and a combination of all three—affect relaxation in cancer survivors. Many cancer patients experience stress and anxiety, and meditation may help reduce distress and improve quality of life. The study enrolls 44 adult cancer survivors with no prior meditation training and will measure how many participants stick with the program and complete assessments over six weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Meditation therapy (breathing, focused attention, mindfulness, and combined techniques)
What this could lead to
If successful, this study could identify which meditation approach best helps cancer survivors relax and manage stress, potentially improving quality of life.
What could go wrong
This is a small pilot study with only 44 participants, so results may not apply to all cancer survivors. The study measures feasibility and relaxation, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

  • City of Hope at Irvine Lennar

    RECRUITING

    Irvine, California, 92618, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.